PofoliaShared via Pofolia

JAMA· 2021Q1

Glaucoma in Adults—Screening, Diagnosis, and Management

Joshua D. Stein, Anthony P. Khawaja, Jennifer S. Weizer

Short summary

Glaucoma, a leading cause of irreversible blindness, can be managed by recognizing systemic risk factors and medications that predispose patients to the condition, enabling timely referral for ophthalmologic examination.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Glaucoma is a leading cause of irreversible blindness, often asymptomatic early on.
  • Systemic conditions and medications (corticosteroids, anticholinergics, antidepressants, topiramate) can increase glaucoma risk.
  • Intraocular pressure is the only modifiable risk factor; older age, nonwhite race, and family history are also key risk factors.
  • Diagnosis involves intraocular pressure measurement, perimetry, and optical coherence tomography.
  • Treatment focuses on lowering intraocular pressure via medications, laser, or surgery.

AI-generated from the title and abstract; the full text is not read.

Abstract

Importance: Glaucoma is the most common cause of irreversible blindness worldwide. Many patients with glaucoma are asymptomatic early in the disease course. Primary care clinicians should know which patients to refer to an eye care professional for a complete eye examination to check for signs of glaucoma and to determine what systemic conditions or medications can increase a patient's risk of glaucoma. Open-angle and narrow-angle forms of glaucoma are reviewed, including a description of the pathophysiology, risk factors, screening, disease monitoring, and treatment options. Observations: Glaucoma is a chronic progressive optic neuropathy, characterized by damage to the optic nerve and retinal nerve fiber layer, that can lead to permanent loss of peripheral or central vision. Intraocular pressure is the only known modifiable risk factor. Other important risk factors include older age, nonwhite race, and a family history of glaucoma. Several systemic medical conditions and medications including corticosteroids, anticholinergics, certain antidepressants, and topiramate may predispose patients to glaucoma. There are 2 broad categories of glaucoma, open-angle and angle-closure glaucoma. Diagnostic testing to assess for glaucoma and to monitor for disease progression includes measurement of intraocular pressure, perimetry, and optical coherence tomography. Treatment of glaucoma involves lowering intraocular pressure. This can be achieved with various classes of glaucoma medications as well as laser and incisional surgical procedures. Conclusions and Relevance: Vision loss from glaucoma can be minimized by recognizing systemic conditions and medications that increase a patient's risk of glaucoma and referring high-risk patients for a complete ophthalmologic examination. Clinicians should ensure that patients remain adherent with taking glaucoma medications and should monitor for adverse events from medical or surgical interventions used to treat glaucoma.

The authors' abstract, as published at the source. JAMA, 2021 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Ophthalmology

OphthalmologyMedicine